{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:07:37Z","timestamp":1785838057023,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1124\/jpet.119.262899","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T20:55:18Z","timestamp":1579121718000},"page":"113-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence"],"prefix":"10.1016","volume":"373","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1219-3968","authenticated-orcid":false,"given":"Sangram","family":"Raut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Garud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-2846","authenticated-orcid":false,"given":"Bhavani","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupama","family":"Sabnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-7280","authenticated-orcid":false,"given":"Alan","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Fudala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1747-9698","authenticated-orcid":false,"given":"Ignacy","family":"Gryczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8086-2791","authenticated-orcid":false,"given":"Zygmunt","family":"Gryczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4835-5885","authenticated-orcid":false,"given":"Sergei V.","family":"Dzyuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4769-5113","authenticated-orcid":false,"given":"Julian","family":"Borejdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-7802","authenticated-orcid":false,"given":"Andras","family":"Lacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.262899_bib1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1124\/jpet.110.167890","article-title":"5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice","volume":"334","author":"Amar","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.262899_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0076-6879(86)28096-9","article-title":"Synthetic peptide analogs of apolipoproteins","volume":"128","author":"Anantharamaiah","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.119.262899_bib3","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1016\/S0021-9258(17)39238-4","article-title":"Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine","volume":"260","author":"Anantharamaiah","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.262899_bib4","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1194\/jlr.R700010-JLR200","article-title":"Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides","volume":"48","author":"Anantharamaiah","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.119.262899_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1567-5688(02)00047-8","article-title":"Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL","volume":"3","author":"Angelin","year":"2002","journal-title":"Atheroscler Suppl"},{"key":"10.1124\/jpet.119.262899_bib6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ Res"},{"key":"10.1124\/jpet.119.262899_bib7","first-page":"II_288","article-title":"Oral administration of the apolipoprotein A-I mimetic peptide D-4F in humans with CHD improves HDL anti-inflammatory function after a single dose (Abstract)","volume":"114","author":"Bloedon","year":"2006","journal-title":"Circulation"},{"key":"10.1124\/jpet.119.262899_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yrtph.2018.10.009","article-title":"Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys","volume":"100","author":"Bourdi","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1124\/jpet.119.262899_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/nn103098m","article-title":"Reconstituted lipoprotein: a versatile class of biologically-inspired nanostructures","volume":"5","author":"Bricarello","year":"2011","journal-title":"ACS Nano"},{"key":"10.1124\/jpet.119.262899_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11883-006-0054-4","article-title":"Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases","volume":"8","author":"Calabresi","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.1124\/jpet.119.262899_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-2275(20)34780-5","article-title":"Animal lipoproteins: chemistry, structure, and comparative aspects","volume":"21","author":"Chapman","year":"1980","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.119.262899_bib12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/jm00352a001","article-title":"Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents","volume":"25","author":"Counsell","year":"1982","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.262899_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.ATV.0000194291.94269.5a","article-title":"What is so special about apolipoprotein AI in reverse cholesterol transport?","volume":"26","author":"Curtiss","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.119.262899_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.189365.112","article-title":"Links between metabolism and cancer","volume":"26","author":"Dang","year":"2012","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.119.262899_bib15","first-page":"483","article-title":"Total and HDL cholesterol in human hematologic neoplasms","volume":"54","author":"Dess\u00ec","year":"1991","journal-title":"Int J Hematol"},{"key":"10.1124\/jpet.119.262899_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI14006","article-title":"CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism","volume":"108","author":"Febbraio","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.119.262899_bib17","doi-asserted-by":"crossref","first-page":"e0203","DOI":"10.1097\/MD.0000000000010203","article-title":"High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in lung adenocarcinoma: a STROBE compliant article","volume":"97","author":"Feng","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1124\/jpet.119.262899_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-2275(20)32028-9","article-title":"Apolipoprotein A-I: structure-function relationships","volume":"41","author":"Frank","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.119.262899_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0005-2736(97)00241-1","article-title":"Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study","volume":"1370","author":"Gallois","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.119.262899_bib20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1432-1033.1996.00879.x","article-title":"The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids","volume":"241","author":"Gallois","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1124\/jpet.119.262899_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3835(94)90008-6","article-title":"Alterations of serum lipids and lipoproteins in breast cancer","volume":"82","author":"K\u00f6ko\u011flu","year":"1994","journal-title":"Cancer Lett"},{"key":"10.1124\/jpet.119.262899_bib23","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/acsnano.5b07522","article-title":"High-density lipoproteins: nature\u2019s multifunctional nanoparticles","volume":"10","author":"Kuai","year":"2016","journal-title":"ACS Nano"},{"key":"10.1124\/jpet.119.262899_bib24","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.2147\/IJN.S140591","article-title":"Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma","volume":"12","author":"Kuai","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/jpet.119.262899_bib25","unstructured":"Lacko AG and Remaley AT (2016) inventors, US Department of Health and Human Services (HHS), University of North Texas Health Science Center, assignee. Drug delivery vehicle. US20150343069A1."},{"key":"10.1124\/jpet.119.262899_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fphar.2015.00247","article-title":"HDL as a drug and nucleic acid delivery vehicle","volume":"6","author":"Lacko","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.119.262899_bib27","doi-asserted-by":"crossref","first-page":"e935","DOI":"10.1016\/j.clgc.2017.05.008","article-title":"Preoperative cholesterol level is associated with worse pathological outcomes and postoperative survival in localized renal cell carcinoma patients: a propensity score-matched study","volume":"15","author":"Lee","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1124\/jpet.119.262899_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0009-3084(89)90049-2","article-title":"Membrane \u201cfluidity\u201d as detected by diphenylhexatriene probes","volume":"50","author":"Lentz","year":"1989","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/jpet.119.262899_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.prp.2016.03.011","article-title":"Up-regulated expression of scavenger receptor class B type 1 (SR-B1) is associated with malignant behaviors and poor prognosis of breast cancer","volume":"212","author":"Li","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1124\/jpet.119.262899_bib30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/clinchem\/27.5.653","article-title":"Cholesterol, lipoproteins, apoproteins, and heart disease: present status and future prospects","volume":"27","author":"Levy","year":"1981","journal-title":"Clin Chem"},{"key":"10.1124\/jpet.119.262899_bib31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/annonc\/mdl477","article-title":"Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (\u2018hand-foot\u2019 syndrome)","volume":"18","author":"Lorusso","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1124\/jpet.119.262899_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.numecd.2008.06.002","article-title":"Serum lipoproteins and cancer","volume":"19","author":"Muntoni","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1124\/jpet.119.262899_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00041433-200412000-00004","article-title":"Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal","volume":"15","author":"Navab","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/jpet.119.262899_bib34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bbrc.2017.10.154","article-title":"Scavenger receptor class B type 1 regulates neuroblastoma cell proliferation, migration and invasion","volume":"495","author":"Panchoo","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.119.262899_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fphar.2016.00326","article-title":"Targeting SR-BI for cancer diagnostics, imaging and therapy","volume":"7","author":"Rajora","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.119.262899_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4155\/tde-2017-0122","article-title":"Lipoproteins for therapeutic delivery: recent advances and future opportunities","volume":"9","author":"Raut","year":"2018","journal-title":"Ther Deliv"},{"key":"10.1124\/jpet.119.262899_bib37","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3389\/fphar.2018.01154","article-title":"Reconstituted HDL: drug delivery platform for overcoming biological barriers to cancer therapy","volume":"9","author":"Raut","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.119.262899_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1124\/jpet.119.262899_bib39","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1194\/jlr.R800034-JLR200","article-title":"The metabolism and anti-atherogenic properties of HDL","volume":"50","author":"Rye","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.119.262899_bib40","first-page":"975","article-title":"Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles","volume":"7","author":"Sabnis","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/jpet.119.262899_bib41","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","article-title":"Lipid metabolism in cancer","volume":"279","author":"Santos","year":"2012","journal-title":"FEBS J"},{"key":"10.1124\/jpet.119.262899_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1593\/neo.101372","article-title":"Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles","volume":"13","author":"Shahzad","year":"2011","journal-title":"Neoplasia"},{"key":"10.1124\/jpet.119.262899_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fphar.2015.00222","article-title":"Antioxidant properties of HDL","volume":"6","author":"Soran","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.119.262899_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/abio.2000.4880","article-title":"Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set","volume":"287","author":"Sreerama","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.119.262899_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/jpet.112.198143","article-title":"Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter","volume":"344","author":"Sviridov","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.262899_bib46","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJM197811302992207","article-title":"Plasma high-density lipoproteins","volume":"299","author":"Tall","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.119.262899_bib47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2016.04.020","article-title":"Lipoproteins and lipoprotein mimetics for imaging and drug delivery","volume":"106","author":"Thaxton","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.119.262899_bib48","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/pros.21499","article-title":"Knockdown of scavenger receptor class B type I reduces prostate specific antigen secretion and viability of prostate cancer cells","volume":"72","author":"Twiddy","year":"2012","journal-title":"Prostate"},{"key":"10.1124\/jpet.119.262899_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.ATV.21.1.13","article-title":"High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport","volume":"21","author":"von Eckardstein","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.119.262899_bib50","doi-asserted-by":"crossref","first-page":"W668","DOI":"10.1093\/nar\/gkh371","article-title":"DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data","volume":"32","author":"Whitmore","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/jpet.119.262899_bib51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/bip.20853","article-title":"Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases","volume":"89","author":"Whitmore","year":"2008","journal-title":"Biopolymers"},{"key":"10.1124\/jpet.119.262899_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat Methods"},{"key":"10.1124\/jpet.119.262899_bib53","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1007\/s13277-015-4141-4","article-title":"High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer","volume":"37","author":"Yuan","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1124\/jpet.119.262899_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fphar.2015.00265","article-title":"Apolipoprotein A-I and cancer","volume":"6","author":"Zamanian-Daryoush","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.119.262899_bib55","doi-asserted-by":"crossref","first-page":"18592","DOI":"10.1021\/jp9618688","article-title":"Distance-dependent fluorescence quenching of p-bis [2-(5-phenyloxazolyl)] benzene by various quenchers","volume":"100","author":"Zelent","year":"1996","journal-title":"J Phys Chem"},{"key":"10.1124\/jpet.119.262899_bib56","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.CIR.0000086981.09834.E0","article-title":"Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524258572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524258572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.262899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:55:48Z","timestamp":1739973348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524258572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0022356524258572"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.262899","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.262899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}